Thank you, Mr. Chair.
Dr. Nickerson, in the previous Parliament, the health committee prepared and produced a report on open science, which recommended developing global access licensing requirements for medicines and vaccines with CIHR funding. To your knowledge, does CIHR have a global access policy for COVID-19 medicines and vaccines developed with public research funding, or does it require institutions receiving CIHR funds to have a global access policy?